<!DOCTYPE html>
<html>
<head>
<title>12_1_MASTER_ALEXION_P03_T05_S02</title>
<meta name="viewport" content="user-scalable=no, width=device-width, initial-scale=1.0, maximum-scale=1.0"/>
<meta name="apple-mobile-web-app-capable" content="yes" />
<meta name="format-detection" content="telephone=no" />


<link href="../global/css/font.css" type="text/css" rel="stylesheet">
<link href="../global/css/global.css" type="text/css" rel="stylesheet">
<link href="css/main.css" type="text/css" rel="stylesheet">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head>
<body>
		<div id="container">
        <div id="main_container" class="bg_orange">
        	<div class="logo"></div>
        <div class="btn_reload"></div>
        	
        
        	
        	<div class="legend005">
            	<h3 class="brown Helvetica_Round_Bold"><i18n id="legent_title005"><span class="font30">VIMOVO</span> significantly 
improves OA pain relief.</i18n></h3>

				<div class="legend005_bottom">
                	
                	<p class="Helvetica_Round_Bold lg_cten1"><i18n id="legend_content1005">overall improvement 
in OA</i18n></p>
					<p class="lg_cten2">as measured by change in 
Patient Global Assessment 
(PGA) scores - Visual Analog 
Scale (VAS) vs placebo at 
12 weeks.<sup>1,*</sup></p>
                
                </div>
                
                <div class=" Helvetica_Round_Bold num005 brown">47%</div>
                
                
                <div class="slide_num avenir_medium">
                    <div id="number_scroll" class="generated ">
                      <div class="scroller"></div>
                    </div>
                    <div class="ok"></div>
                </div>
                
            </div>
            
            
            <div class="right_content005">
                <div class="chart_bg005">
                	<ul class="chart_num005 HelveticaNeueLTStd_bold">
                    	<li class="chart_numcol1">14.4</li>
                        <li  class="chart_numcol2">21.6</li>
                        <li  class="chart_numcol3">21.2</li>
                    </ul>
					<div class="line_2colbg"></div>
                    <div class="line_3shadow"></div>
					<div class="wrapper">
						<div class="line_2col"></div>
						
						<div class="line_3col"></div>
					</div>
                
                </div>
                <div class="verticle_txt005"><i18n id="verticle_txt005">LS Mean Change from Baseline in<br>
    PGA-VAS Scores at 12 Weeks</i18n></div>

                <div class="foot_note HelveticaLTStd_Roman">Results from a second study demonstrated similar results<br />
                (PBO 21.4, VIMOVO 29.0, celecoxib 25.6, p < 0.05 VIMOVO vs PBO, <br />p = ns celecoxib vs PBO, p = ns VIMOVO vs celecoxib)<sup>1</sup></div>
                <ul class="list1005">
                	<li><span class="blue upercase HelveticaNeueLTStd_bold"><i18n id="list005_1">Vimovo</i18n></span> (n = 242)</li>
                    <li><span class="black">Celecoxib</span> (n = 230)</li>
                    <li>Placebo (n = 124)</li>
                </ul>
                <p class="list2005"><i18n id="list2005">p = 0.018 VIMOVO vs PBO <br>      
p = 0.013 celecoxib vs PBO <br>     
p = ns VIMOVO vs celecoxib</i18n></p>
            	
            </div>
            
           	<div class="claim">
                <i18n id="claim005">It starts with effective OA<sup>‡</sup> pain relief.</i18n>
            </div>
        </div>
        <!--End #main_container -->
        <div class="ref_wrapper" id="ref_all"></div>	
        <div id="scroll-wrapper" class="scroll_ref">
			<div id="scroller">	
                <h1 class="brown Helvetica_Round_Bold"><i18n id="v1_v1_S007_ref">References:</i18n></h1>
                
				<div class="ref HelveticaLTStd_Roman">
               		<span class="ref_number">1.</span>
                	<i18n id="v1_v1_S007_ref_txt0">Hochberg, MC, et al. <i>Curr Med Res Opin</i> 2011; 27(6): 1243-53.</i18n>
                </div>	
				
                <div class="ref HelveticaLTStd_Roman">
					<span class="ref_number">‡</span>
                    <i18n id="v1_v1_S007_ref_txt4">
					Osteoarthritis
                    </i18n>
				</div>  <!--end Ref-->
                
                <div class="ref HelveticaLTStd_Roman">
					<span class="ref_number">*</span>
                    <i18n id="v1_v1_S007_ref_txt7">
					The Patient Global Assessment (PGA) questionnaire used in these studies assessed patients' perceptions of their OA pain. Patients were asked, "Considering all the ways your arthritis affects you, how well are you doing?" This was completed at baseline and Weeks 1, 6, and 12 via electronic diaries; responses ranged between "Very poor" and "Excellent" using a 100mm Visual Analog Scale (VAS).<sup>Source: see note 1 above</sup>
                    </i18n>
				</div>	
			</div>
            <div class="close"><span class="right"></span></div>
            <div class="arrow_ref"></div>
		</div>
            		
		<!--End area for ref-->
        
        <div class="info_wrapper" id="info_all"></div>	
		<div id="scroll-wrapper" class="scroll_info">
			<div id="scroller">	
                <h1 class="brown Helvetica_Round_Bold"><i18n id="v1_v1_S007_ref">Pain Efficacy Trials:</i18n></h1>
				
				<div class="ref HelveticaLTStd_Roman">
               		<span class="ref_number">&bull;</span>
                	<i18n id="info1">Patients with OA of the knee </i18n>
                </div>	
				
                <div class="ref HelveticaLTStd_Roman">
					<span class="ref_number">&bull;</span>
                    <i18n id="info2">50 and older with a 6-month history of symptomatic, clinically diagnosed OA</i18n>
				</div>  <!--end Ref-->
                
                <div class="ref HelveticaLTStd_Roman">
					<span class="ref_number">&bull;</span>
                    <i18n id="info3">PGA-VAS scores and WOMAC Pain and Function scores were similar between VIMOVO and celecoxib 200mg daily in this study comparing lecoxib, VIMOVO, and placebo over 12 weeks.</i18n>
				</div>			
               
			</div>
            <div class="close"><span class="right"></span></div>
			<div class="arrow_info"></div>
		</div>
        </div>
</body>
	<script type="text/javascript" src="../global/js/config.js"></script>
    <script type='text/javascript' src='../framework/steal/steal.production.js?../framework,development'></script>
	
	<script src="resource:js/SystemBridge.js"></script>
	<script type="text/javascript" src="../global/js/havie.js"></script>
    <script type="text/javascript" src="../global/js/global.js"></script>
    <script type="text/javascript" src="../global/js/ref.js"></script>
    
     <script type="text/javascript" src="javascript/utils.js"></script>
     <script type="text/javascript" src="javascript/widget.js"></script>
     <script type="text/javascript" src="javascript/iscroll.js"></script>
     <script type="text/javascript" src="javascript/scroll.js"></script>
     <script type="text/javascript" src="javascript/picker.js"></script>
    <script type="text/javascript" src="javascript/main.js"></script>	
</html>

